Please login to the form below

Not currently logged in
Email:
Password:

sapropterin dihydrochloride

This page shows the latest sapropterin dihydrochloride news and features for those working in and with pharma, biotech and healthcare.

Judge forces NHS England rethink on Kuvan

Judge forces NHS England rethink on Kuvan

BioMarin won EU approval in 2008 for Kuvan (sapropterin dihydrochloride), a drug that is used alongside a phenylalanine-restricted diet to reduce levels of amino acid even further, but so far

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2015 Deal Watch October 2015

    In the original PKU-focused deal dating back to 2005, Merck signed an exclusive licence with BioMarin for the oral drug Kuvan (sapropterin dihydrochloride), which is now marketed, and an option

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
fox&cat

up to your ears in it? some pressure is helpful but too much of the wrong sort quickly takes its...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics